Items Tagged ‘long QT syndrome’
April 1, 2021 · Leave a Comment
Research News Roundup — Q1 2021
The first quarter of 2021 saw furthered understanding the SARS-CoV-2 virus and related COVID-19 viral infection. In addition, a number of advances occurred including in genetics knowledge, cancer treatments, as well as interinstitutional collaborations, expanding programs and recognition of some of the most exceptional contributions of current and former Mayo Clinic clinician-scientists. Mayo Clinic, Thermo Fisher […]
View full entry Comment on this
Tags: Arizona State University, biomarkers, brain cancer, BRCA2, breast cancer, chemotherapy, COVID-19, David Holmes Jr., diversity, education, Fergus Couch, gene varient
February 22, 2021 · Leave a Comment
Mayo Clinic Research in the news — 2/22/2021
Over the last week, Mayo Clinic researchers and expertise have been cited in wide range of news stories, from the ever present COVID-19 to telehealth, participation in cancer clinical trials, creatine supplements, artificial intelligence and more. Read on for headlines, excerpts and links. ‘Knowledge is Power’: Advocating for More Representation in Cancer-Related Clinical Trials Cure, […]
View full entry Comment on this
Tags: Andrew Jagim, artificial intelligence, Bernard Gersh, blood pressure, Brian Pickering, cancer, CAR T-cell therapy, cardiology, cardiovascular medicine, clinical trials, COVID-19, FDA
February 16, 2021 · Leave a Comment
First hybrid gene therapy shows early promise in treating long QT syndrome
In a new study published in Circulation, Mayo Clinic researchers provide the first preclinical, proof-of-concept study for hybrid gene therapy in long QT syndrome, a potentially lethal heart rhythm condition. Researchers demonstrated its potential therapeutic efficacy in two in vitro model systems using beating heart cells reengineered from the blood samples of patients with type 1 long […]
View full entry Comment on this
Tags: cardiology, cardiovascular disease, cardiovascular medicine, Center for Individualized Medicine, Center for Regenerative Medicine, gene therapy, long QT syndrome, Michael Ackerman, molecular pharmacology and experimental therapeutics, pediatric cardiology, pediatric research, sudden cardiac death
July 28, 2020 · Leave a Comment
Using stem cells to find causes and treatments to prevent sudden cardiac death
Mystified by the need for defibrillation to save a 10-year-old from drowning, Michael Ackerman, M.D., Ph.D., vowed to dig for answers. That pivotal case during a Mayo Clinic pediatric cardiology residency was the catalyst for Dr. Ackerman’s career in genetic sleuthing of inherited sudden cardiac death syndromes. With help from the Center for Regenerative Medicine […]
View full entry Comment on this
Tags: Brugada syndrome, Center for Regenerative Medicine, hypertrophic cardiomyopathy, induced pluripotent stem cells, long QT syndrome, Michael Ackerman, regenerative medicine, sudden cardiac death